Digene to develop DNA test for herpes:
This article was originally published in Clinica
Digene has received a grant from the US National Institutes of Health to develop a DNA test for the herpes simplex virus (HSV) based on the company's Hybrid Capture II technology. The company plans to use the $750,000 award to develop a simple, sensitive and cost-effective test to improve detection, screening and monitoring of patients with HSV Types 1 and 2 infection. The Beltsville, Maryland-based company estimated that three to five million HSV tests are performed annually in the US, while six to 10 million are carried out worldwide.